Prohibitin, a tumor suppresser protein, plays an important role in the transcriptional regulation of various genes involved in cell-cycle control and proliferation. Recent studies have reported that the growth-suppressive property of the prohibitin protein is exhibited in its physical interaction with E2F family proteins and its subsequent repression of their transcriptional activity. Herein, we report that prohibitin interacts with RING finger protein 2 (RNF2), a member of the PcG (polycomb-group) family of proteins, and that the two proteins regulate the activity of E2F1 via dual pathways: the direct, prohibitin-mediated pathway and the indirect, p16-mediated pathway of E2F1 transcriptional regulation. Co-immunoprecipitation experiments showed that endogenous prohibitin interacts with endogenous RNF2. Interestingly, the expressed amounts of RNF2 and prohibitin were interdependently affected at the post-translational level. Furthermore, the depletion of either endogenous RNF2 or prohibitin using the RNA interference technique increased the level of p16 protein expression, resulting in a decrease in the transcriptional activity of E2F1 via the p16-CDK4-Rb pathway. In addition, chromatin immunoprecipitation assays showed that RNF2 was recruited to E2F1-response promoters along with prohibitin to inhibit the transcriptional activity of E2F1. Cell proliferation was also regulated by the prohibitin-RNF2 interaction. These results suggest that the RNF2-prohibitin complex regulates the activity of E2F1 via dual pathways.
Introduction
Prohibitin is an evolutionarily conserved and ubiquitously expressed protein. Prohibitin has the potential to act as a tumor suppressor, antiproliferative protein and regulator of cell-cycle progression in the nucleus. The roles of prohibitin are accomplished by its interaction with E2F, pRb and p53 (Wang et al., 1999a; Fusaro et al., 2003) .
The transcriptional activator E2F1 has been shown to upregulate the expression of many genes involved in differentiation, proliferation and apoptosis, and it plays a major role in the G1/S transition and DNA synthesis (Bell and Ryan, 2004) . Prohibitin represses the transcriptional activity of E2Fs1-5 by recruiting co-repressors, including histone deacetylase 1, N-CoR and BrG1/ Brm (Wang et al., 2002) , whereas Rb represses the transcriptional activity of E2Fs1-3 by recruiting histone deacetylase 1, DNA methyltransferase and BrG1/Brm (Luo et al., 1998; Magnaghi-Jaulin et al., 1998; Zhu, 2005) . Prohibitin and Rb interact with distinct regions of E2F1 and respond to different upstream signals (Wang et al., 1999b) .
The Rb protein negatively controls the G1/S phase transition of the cell cycle, thus acting as a tumor suppressor. At the beginning of G1, Rb proteins exist in an active, non-phosphorylated state that allows them to bind to a large number of proteins, including E2F1 (Harbour and Dean, 2000) . E2F1 is functionally inactive when bound to Rb. The Rb proteins are inactivated by phosphorylation mediated by various cyclin-dependent kinases (Cdks). D-type cyclins synthesized in the early G1 phase confer catalytic activity to Cdk4 and Cdk6. The activated Cdk4/6-cyclin D complexes phosphorylate Rb, which dissociates Rb from the transcription activator E2F1, thus activating E2F1. The p16 protein binds to the non-catalytic side of Cdk4 and Cdk6 and blocks the interaction between Cdk4/6 and cyclin D (Sherr, 2000) .
RING finger protein 2 (RNF2), also known as dinG/RING1b, was previously identified as a member of the PcG family (polycomb group). RNF2 acts as a transcriptional repressor and contains a conserved RING finger domain in its N-terminal region. We previously found that the RNF2 protein plays the role of an E3 ligase and that RNF2 interacts with the S6' protein (Lee et al., 2001 . It was recently found that the RNF2-containing polycomb-group complexes participate in histone H2A ubiquitination (Wang et al., 2004) . Interestingly, Voncken et al. (2003) reported that the RNF2-null mouse embryo arrests at the early developmental stage, but the arrest is bypassed by the genetic inactivation of the p16 locus, suggesting that RNF2 is involved in the p16-CDK4-Rb pathway.
Herein, our in vivo binding experiment shows that the RNF2 protein interacts with prohibitin. Furthermore, our results demonstrate that the two proteins regulate the function of E2F1 by dual pathways: the direct, prohibitin-mediated pathway and the indirect, p16-mediated pathway of E2F1 translational regulation.
Results
Interaction between RNF2 and prohibitin in mammalian cells We used a yeast two-hybrid screen to identify the proteins that interacted with RNF2 and found that prohibitin interacted with RNF2 (data not shown). We performed co-immunoprecipitation experiments in HEK293 cells and confirmed the RNF2-prohibitin interaction in mammalian cells (Supplementary Figure  S1a) . To investigate whether endogenous prohibitin interacts with endogenous RNF2, we performed coimmunoprecipitation experiments in HEK293 cells using antibodies against prohibitin (Figure 1 , right panel) or RNF2 (Figure 1 , left panel). The precipitated proteins were then immunoblotted for the RNF2 antibody and prohibitin antibody, respectively. Endogenous cellular RNF2 was found in immunocomplexes with prohibitin, while endogenous prohibitin was found in immunocomplexes with RNF2. The RNF-prohibitin interaction was also found in HeLa and MCF7 cells (Supplementary Figure S1b) . Furthermore, we used prohibitin deletion mutants to define the interaction domain and found that RNF2 interacts with the N-terminus of prohibitin (Supplementary Figure S1c) . Taken together, these results demonstrate that endogenous protein complexes containing prohibitin and RNF2 exist in various cell lines.
The stability of RNF2 and prohibitin was regulated interdependently at the post-translational level We investigated the expression levels of the two proteins, since one protein might influence the stability of the other protein if they interact each other. The effect of RNF2 on prohibitin stability was initially analysed in HEK293 cells transfected with HA-tagged RNF2 and/or the RNF2 shRNA (short interfering hairpin RNA) expression vector. Interestingly, the level of the prohibitin protein was increased when RNF2 was overexpressed, while the level of prohibitin was not increased when HA-tagged RNF2 and RNF2 shRNA expression vectors were co-transfected (Figure 2a) . To further investigate, we performed a knockdown of Interaction between prohibitin and RNF2 D Choi et al endogenous RNF2 using a RNF2 shRNA expression vector and found that the knockdown of RNF2 decreased the levels of the prohibitin protein (Figure 2b) . However, the stability of D-prohibitin, a member of prohibitin superfamily, was not influenced by the RNF2 knockdown.
We also investigated the effect of prohibitin on RNF2 expression. As shown in Supplementary Figure S2a , the level of RNF2 was increased by the overexpression of prohibitin. We also tested the effect of knockdown of endogenous prohibitin by using prohibitin shRNA expression vectors (Supplementary Figure S2b) . Prohibitin knockdown using shprohibitin-1 reduced the level of RNF2.
Taken together, these results showed that RNF2 and prohibitin interdependently regulate the stability of the other proteins.
We used a variety of experimental approaches in an effort to gain insight into the mechanism responsible for the interdependent regulation of prohibitin and RNF2 stability. We performed real-time reverse transcription-PCR experiments to determine whether the interdependent regulation of prohibitin and RNF2 was carried out at the transcriptional or post-transcriptional level. As shown in Figure 3a , the knockdown of RNF2 using RNA interference (RNAi) led to a reduction in the levels Interaction between prohibitin and RNF2 D Choi et al of RNF2 mRNA. However, RNF2 knockdown had no effect on the level of endogenous prohibitin mRNA. At this point, we knocked down the expression of prohibitin using shprohibitin-1, which did not reduce the level of endogenous RNF2 mRNA ( Figure 3b ). These results show that the interdependent regulation of prohibitin and RNF2 stability is not carried out at the level of transcription.
We then investigated whether the interdependent regulation of prohibitin and RNF2 stability occurs at the post-translational level. HEK293 cells were transfected with the control vector or prohibitin (Figure 3c ). At 48 h after transfection, the cells were treated with cycloheximide to block protein synthesis. As shown in Figure 3c , RNF2 showed a half-life of about 60 min. RNF2 decayed at a slower rate in the presence of ectopically expressed prohibitin; the half-life of RNF2 was increased to more than 90 min. These observations strongly suggest that RNF2 is more stabilized by its interaction with prohibitin and that the interdependent regulation of prohibitin and RNF2 stability occurs at the post-translational level.
Protein levels of p16 are increased by prohibitin or RNF2 depletion In the previous report, the expression of p16
INK4a was found to be upregulated in RNF2-knockout mice (Voncken et al., 2003) . We tested whether the protein expression level of endogenous p16 is affected by the overexpression or knockdown of RNF2 in HEK293 cells ( Figure 4a ). As expected, the downregulated expression of RNF2 increased endogenous p16 protein levels. Interestingly, the overexpression of RNF2 did not increase or decrease the protein level of p16.
Since our study showed that RNF2 interacts with prohibitin, we investigated whether prohibitin also influences the level of p16, as was shown with RNF2. We investigated the endogenous p16 protein levels in HEK293 cells with overexpressed prohibitin or in HEK293 cells with reduced prohibitin by RNAi (Figure 4b) . The results were the same as those observed with RNF2: prohibitin knockdown resulted in a marked increase in p16 expression, but the level of p16 was not altered by prohibitin overexpression. In addition, we tried to test other cell lines and obtained similar results in MEF cells treated with prohibitin siRNA oligonucleotides (Figure 4b ). These results demonstrate that the decrease in either RNF2 or prohibitin opens the door for p16 upregulation.
The expression of p16 is regulated by prohibitin through RNF2 We defined the prohibitin region responsible for regulating the stability of RNF2 and whose knockdown increases the level of p16. We analysed the endogenous p16 protein levels in HEK293 cells transfected with deleted versions of prohibitin: prohibitin D185-214 Interaction between prohibitin and RNF2 D Choi et al (deletion of E2F1-binding site), prohibitin 1-185, prohibitin D1-185 and prohibitin 1-214. As shown in Figure 5a , the protein levels of RNF2 were increased not only by fulllength prohibitin, but also by the deleted versions of prohibitin except for prohibitin D1-185, suggesting that the protein stability of RNF2 is not regulated by the E2F1-binding site of prohibitin, but rather by prohibitin 1-185. We analysed the p16 protein levels in HEK293 cells cotransfected with a prohibitin shRNA expression vector and a deleted version of prohibitin (Figure 5b) . The knockdown of prohibitin expression using RNAi increased the amount of p16 (Figure 5b, lane 2) . However, the effect was rescued by the overexpression of either full-length prohibitin or the deleted versions. Moreover, similar results were also obtained in cells co-transfected with a prohibitin shRNA expression vector and RNF2. These results suggest that absence of prohibitin might make RNF2 unstable, which would promote the expression of p16.
Prohibitin is able to regulate E2F1 transcription activity via the p16-CDK4 pathway Our results, presented in Figure 4 , showed that the decrease in prohibitin expression induced the upregulation of p16 expression, which gave us the idea that prohibitin might indirectly regulate the transcriptional activity of E2F1 through the p16-CDK4-Rb pathway. To determine whether the level of phosphorylated Rb is decreased by prohibitin knockdown, we transfected prohibitin siRNA oligonucleotides into MEF cells and observed the amount of phosphorylated Rb using western Interaction between prohibitin and RNF2 D Choi et al blotting and by probing with a specific antibody against a short amino-acid sequence containing phosphorylated Ser 807 and Ser 811 of Rb. As shown in Figure 6a , the level of phosphorylated Rb was reduced in the cells transfected with prohibitin siRNA oligonucleotides. The region spanning amino-acid residues 185-214 of prohibitin is the E2F1-binding site and is required for the repression of E2F1 transcriptional activity. To confirm whether prohibitin residues 185-214 are required to repress the transcriptional activity of E2F1, we constructed E2F1 fused to the Gal4-DNA-binding domain. We then examined the effect of prohibitin on the activity of the Gal4-E2F1 protein by transient-transfection experiments in HEK293T cells. As shown in Figure 6b , the Gal4-E2F1 construct could induce transcription from a pFR trans-Reporter plasmid containing the luciferase reporter gene, but co-transfection with Gal4-E2F1 and prohibitin reduced the transcriptional activity of the Gal4-E2F1 protein. However, as expected, co-transfection with Gal4-E2F1 and the E2F1-binding domain deletion mutant of prohibitin (prohibitin D185-214) had no effect on the transcription induced by Gal4-E2F1.
To gain insight into the mechanism underlying the regulation of E2F1 transcriptional activity by prohibitin, we analysed the change in E2F1 transcriptional activity caused by the knockdown of prohibitin expression (Figure 6c ). Interestingly, the decreased level of prohibitin did not drastically change the transcriptional activity of E2F1. We also tested the transcriptional activity of E2F1 in HEK293T cells co-transfected with prohibitin D185-214 and shprohibitin-1. Although prohibitin D185-214, which lacks the E2F1 binding domain, was not able to directly repress the transcriptional activity of E2F1, it reduced the p16 protein level that had been increased by prohibitin knockdown using the transfection of shprohibitin-1. It is important to note that shprohibitin-1 is not able to Interaction between prohibitin and RNF2 D Choi et al knockdown transfected prohibitins, including prohibitin D185-214, because it targets the 3 0 UTR region of prohibitin. The transcriptional activity of E2F1 was remarkably increased in HEK293T cells co-transfected with prohibitin D185-214 and shprohibitin-1. These results suggest that prohibitin regulates the transcriptional activity of E2F1 not only by direct binding to E2F1, but also through the p16-CDK4-Rb pathway.
RNF2 is recruited to the E2F1-binding promoters and plays a role in the prohibitin-mediated repression of E2F1 transcriptional activity It was previously reported that the p16 expression level was increased in RNF2-knockout mice (Voncken et al., 2003) . We also found that RNF2 interacted with prohibitin. We therefore used a luciferase reporter assay to assess whether RNF2 influenced the transcriptional activity of E2F1 through the p16-CDK4-Rb pathway. The pFR trans-Reporter plasmids containing the luciferase gene and Gal4-E2F1 were co-transfected into HEK293T cells. Unexpectedly, transfection with either the RNF2 shRNA expression vector or RNF2 slightly altered the transcriptional activity of E2F1 (Figures 7a  and b) . However, co-transfection with RNF2 and prohibitin resulted in a synergistic repression of E2F1 transcriptional activity (Figure 7c ), indicating that RNF2 plays roles not only in the regulation of the p16-Rb-E2F1 pathway, but also in the prohibitinmediated repression of E2F1 activity.
To confirm that RNF2 is involved in the prohibitinmediated repression of E2F1 activity, we investigated whether RNF2 and prohibitin are co-recruited to the E2F1-binding promoters using chromatin immunoprecipitations (ChIP). Using anti-prohibitin antibodies, we initially immunoprecipitated chromatin from HEK293 cells and performed ChIP PCR with E2F1, TK and p107 primers, which were previously reported to be prohibitin-recruiting promoters (Wang et al., 2002) . As expected, prohibitin was recruited to the promoters Interaction between prohibitin and RNF2 D Choi et al tested (Figure 7d , left panel). We also performed ChIP using anti-RNF2 antibody and ChIP PCR using the same primers. As shown in Figure 7d (right panel), RNF2 also associated with the tested promoters, suggesting that RNF2 and prohibitin are co-recruited to the E2F1-binding promoters.
The change in cell proliferation by the interaction with RNF2 and prohibitin E2F1 regulates the expression of genes involved in the cell cycle and proliferation, and thus, the exogenous expression of E2F1 in quiescent cells results in S phase entry. This study showed that the transcriptional activity of E2F1 was increased in cells co-transfected with prohibitin D185-214 and the shprohibitin-1 expression vector and that it was decreased in cells cotransfected with prohibitin and RNF2. To determine whether cell proliferation is affected by the interaction between RNF2 and prohibitin, we investigated cell proliferation using a colony formation assay after transfection with vectors encoding RNF2, prohibitin, prohibitin D185-214 and/or shprohibitin-1, as indicated Interaction between prohibitin and RNF2 D Choi et al in Figure 8 . The proliferation rate was higher in cells cotransfected with prohibitin D185-214 and siprohibitin-1 than in cells transfected with shprohibitin-1 alone or with the control vector (Figure 8a ). However, the rate of proliferation was much lower in cells co-transfected with prohibitin and RNF2 than in cells transfected with just the control vector, RNF2 or prohibitin (Figure 8b ). In addition, Supplementary Figure S3 showed that the reduced number of colony formation was not caused by apoptosis. Taken together, these results demonstrate that the rate of cell proliferation is also influenced by the interaction between RNF2 and prohibitin.
Discussion
Prohibitin has been known to repress the transcriptional activity of E2F1 by physically interacting with E2F1. Our study shows that RNF2 is involved in the direct repression of the transcriptional activity of E2F1. Alternatively, Rb represses the transcriptional activity of E2Fs1-3 through the recruitment of histone deacetylase 1, DNA methyltransferase and BrG1/Brm (Zhu, 2005) . At the beginning of the G1 phase of the cell cycle, Rb exists in a non-phosphorylated state, which allows the protein to bind E2F1, resulting in the inactivation of E2F1. The Cdk4/6-cyclin D complexes phosphorylate Rb, which dissociates Rb from the transcriptional activator E2F1, leading to the activation of E2F1. The p16 protein binds to Cdk4/6 and blocks the interaction between Cdk4/6 and cyclin D. Our results presented in Figure 4 show that decreases in prohibitin result in the upregulation of p16 expression, suggesting that prohibitin might indirectly regulate the transcriptional activity of E2F1 through the p16-CDK4-Rb pathway. Thus, we demonstrated that prohibitin and RNF2 regulate the function of E2F1 by dual pathways: the direct, prohibitin-mediated pathway and the indirect, p16-mediated E2F1 pathway of transcriptional regulation ( Figure 9 ). Co-transfection with shprohibitin-1 and prohibitin D185-214, which lacks the E2F1-binding domain, would decrease the amount of prohibitin that directly represses the transcriptional activity of E2F1, but would not change the levels of the p16 protein, resulting in an increase in the transcriptional activity of E2F1. It is important to note that shprohibitin-1 is not able to knockdown transfected prohibitins, including prohibitin D185-214, because it targets the 3 0 UTR region of prohibitin. However, transfected prohibitin DNA does not contain the 3 0 UTR region. To prove this hypothesis, we tested the transcriptional activity of E2F1 in HEK293T cells co-transfected with prohibitin D185-214 and shprohibitin-1. Figures 5b and 6c show that the p16 protein levels were not changed and that the transcriptional activity of E2F1 was remarkably increased in HEK293T cells co-transfected with prohibitin D185-214 and shprohibitin-1. These results support our hypothesis that the decrease in prohibitin might downregulate the transcriptional activity of E2F1 through the p16-CDK4-Rb pathway.
We hypothesized that the E2F1-binding domainmutated prohibitins might be tumorigenic because mutations in the E2F1-binding site would inhibit the interaction between prohibitin and E2F1, but the expression level of p16 would be maintained, as was shown in our study. In previous reports, we found cases of sporadic breast cancer caused by mutations in the E2F1-binding site (Sato et al., 1993) . This case study also supports the finding that RNF2 and prohibitin regulate E2F1 function by dual pathways.
Materials and methods
Plasmids, cell culture and transfection Details are given in Supplementary Information.
RNA interference of RNF2 and prohibitin
For vector-based RNF2 and prohibitin RNAi, 53 bp oligonucleotide duplexes containing sequences specific to a portion of the RNF2 or prohibitin coding sequences were cloned into the pSilencer1.0-U6 shRNA expression vector according to the manufacturer's instructions (Ambion, Austin, TX, USA). Details are submitted as Supplementary Information.
Quantitative-reverse transcription-PCR Details on the method of quantitative-reverse transcription-PCR are given in Supplementary Information.
Protein half-life experiments
We performed protein half-life experiments using a modification of previously published methods (Kim et al., 2004) . At 48 h after transfection, HEK293 cells were treated with 40 mg ml À1 of cycloheximide (Sigma, St Louis, MO, USA) for the indicated durations. The cells were harvested and lysed. The extracts were analysed by western blot and probed with the anti-RNF2 antibody.
Luciferase reporter assays Details regarding luciferase reporter assays are given in Supplementary Information.
Co-immunoprecipitation
Details are given in Supplementary Information.
Chromatin immunoprecipitations
We performed ChIP using a modification of previously published methods (Shang et al., 2000) . Details are submitted as Supplementary Information.
Colony formation assay HEK293 cells (1 Â 10 5 ) transiently transfected with a control vector, prohibitin, RNF2, prohibitin D185-214 or an shprohibitin expression vector, were seeded in a 100-mm dish and cultured in G418 (3 mg ml À1 )-supplemented medium (DMEM plus 8% FBS). After 15 days, G418-resistant colonies were counted using methyl blue staining (Yoo et al., 2005) .
